Showing results (231-240 of 247) with videos related to
Sort By:
Pageof 25
Brain : a Journal of Neurology|May 1, 2012
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylationSteven Petratos, Ezgi Ozturk, Michael F Azari, et al.Annals of Clinical and Translational Neurology|March 27, 2019
Anti-PrPC antibody rescues cognition and synapses in transgenic alzheimer miceTimothy O Cox, Erik C Gunther, A Harrison Brody, et al.Alzheimer'S Research & Therapy|January 20, 2020
PET imaging of mGluR5 in Alzheimer's diseaseAdam P Mecca, Julia W McDonald, Hannah R Michalak, et al.Alzheimer'S Research & Therapy|April 16, 2015
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseHaakon B Nygaard, Allison F Wagner, Garrett S Bowen, et al.The Journal of Biological Chemistry|August 7, 2004
A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelinWeiwei Li, Lee Walus, Sylvia A Rabacchi, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 5, 2008
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growthStéphane Budel, Thihan Padukkavidana, Betty P Liu, et al.Brain Communications|April 24, 2023
Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis modelSining Ye, Paschalis Theotokis, Jae Young Lee, et al.JAMA Neurology|July 23, 2019
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical TrialChristopher H van Dyck, Haakon B Nygaard, Kewei Chen, et al.Science Translational Medicine|June 1, 2022
Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1QJoshua Spurrier, LaShae Nicholson, Xiaotian T Fang, et al.Cell Reports|January 4, 2019
Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein AntagonistsErik C Gunther, Levi M Smith, Mikhail A Kostylev, et al.Pageof 25